ALiEM - Pharm Pearls

NOVEMBER 1, 2023

McGraw-Hill Education; 2019 Madiwale T, Liebelt E. Hypersensitivity reactions to rifampin: Pathogenetic mechanisms, clinical manifestations, management strategies, and review of the anaphylactic-like reactions. Clinical pharmacology, therapeutic use and potential of COMT inhibitors in Parkinson’s disease.

Clinical Pharmacology 161

Clinical Pharmacology Dosage Compounding 161

PharmD Live

MAY 30, 2024

British Journal of Clinical Pharmacology, 67(6), 689–700. Retrieved from British Journal of Clinical Pharmacology Jyrkka, J., British Journal of Clinical Pharmacology, 74(4), 627–633. Retrieved from British Journal of Clinical Pharmacology Family Caregiver Alliance. A., & O’Mahony, M.

Clinical Pharmacology 119

Clinical Pharmacology Hospitals Long-Term Care Facilities Dosage 119

pharmaphorum

JANUARY 29, 2021

Researchers from the University of East Anglia (UEA) in collaboration with Boots UK and Leiden University analysed 2019 NHS dispensing data across the UK. This would have reduced their risk of side effects and could have led to better clinical outcomes.”. Estimating the potential impact of implementing pre?emptive

Clinical Pharmacology 98

Clinical Pharmacology Community Pharmacies 98

RX Note

APRIL 16, 2023

External Links Disease Management: A Guide to Clinical Pharmacology, 2016 Rang & Dale’s Pharmacology, 2019 Nonetheless, domperidone should be avoided in patients with conduction disorders or cardiac disease due to its association with Q-T interval prolongation.

Clinical Pharmacology 52

Clinical Pharmacology 52

pharmaphorum

MARCH 11, 2022

Vraylar, sold in some markets as Reagila, was first approved in 2015 for schizophrenia and bipolar disorder, with its label extended in 2017 to include maintenance treatment of schizophrenia and again in 2019 for bipolar depression.

Clinical Pharmacology 52

Clinical Pharmacology Labelling 52

RX Note

JANUARY 21, 2023

Adverse Drug Reaction Drug Induced Diseases, 2018 Meyler's Side Effects of Drugs, 2015 Antibiotics The Sanford Guide to Antimicrobial Therapy, 2022 Breastfeeding Briggs' Drugs in Pregnancy and Lactation, 2021 Hale's Medications and Mothers' Milk, 2021 Clinical Practice Applied Therapeutics, 2018 Conn’s Current Therapy, 2022 Current Medical Diagnosis (..)

Compounding 40

Compounding Community Pharmacies Clinical Pharmacology Dosage 40

European Pharmaceutical Review

MARCH 11, 2024

As we advance these ultra long-acting options through clinical research and regulatory approval, we will not lose sight of our promise to leave no person living with HIV behind. About the author Sherene Min, MD, MPH, is Vice President of Global Clinical Development at ViiV Healthcare , a role she assumed in October 2019.

Immunity 98

Immunity Immunization Clinical Pharmacology Drug Development 98